Fig. 2: Sensitivity and Specificity of CTCs and CAMLs in Pancreatic cancer patients referred for resection. | npj Precision Oncology

Fig. 2: Sensitivity and Specificity of CTCs and CAMLs in Pancreatic cancer patients referred for resection.

From: Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes

Fig. 2

a Frequency of CTCs (>1 cell/sample), CEA (>5 ng/mL), CA19-9 (>37 µg/mL), and CAMLs (>1 cell/sample) as they relate to resectability. b ROC curve showing the specificity/sensitivity of CAMLs (red) and CTCs (blue) in comparison with 40 healthy controls.

Back to article page